Baxter International Inc. (0QK8)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 25.01 |
|---|---|
| 52-week range | 15.74 – 26.58 |
| Return, 1 month / 3 months | +7.1% / +10.1% |
| Return, 1 year / 3 years | +7.9% / −18.0% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 43.0% |
| Worst drawdown (1 year) | -29.1% |
| Average daily value traded | 0.07M USD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Baxter International is a healthcare products company based in the United States. It makes and supplies medical products used in hospitals and clinics, including intravenous solutions, infusion systems, parenteral nutrition, and equipment and supplies for kidney dialysis and surgical care. Its customers are mainly healthcare providers, hospitals and clinics that use these products in patient treatment and care. The company also provides related medical devices and therapies for chronic and acute conditions.
Baxter International Inc. trades under the code 0QK8 on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Baxter International Inc. (0QK8) trades on the London Stock Exchange in UK. It last closed at USD 25.01 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,434 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.9% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.0% | ||
| From 52-week high | -4.3% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | 35.9% | ||
| 12-month return, skipping the last month | 0.8% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.1% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.07M USD | ||
| Zero-volume days | 26.7% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | +7.1% |
| 3 months | +10.1% |
| 6 months | +35.9% |
| 1 year | +7.9% |
| 3 years | −18.0% |
| 5 years | −66.3% |
Signals
| 50-day / 200-day average | 24.07 / 20.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.69 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | USD 0.0100 |
| 29 May 2026 | USD 0.0100 |
| 27 Feb 2026 | USD 0.0100 |
| 28 Nov 2025 | USD 0.0100 |
| 29 Aug 2025 | USD 0.1700 |
| 30 May 2025 | USD 0.1700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.